S&P Futures
4,033.75 -2.00 (-0.05%) Dow Futures
32,773.00 -1.00 (-0.00%) Nasdaq Futures
12,847.75 -19.50 (-0.15%) Russell 2000 Futures
1,794.40 +1.10 (+0.06%) Crude Oil
69.31 -0.36 (-0.52%) Gold
1,947.30 +6.20 (+0.32%)
Inspire Medical Systems, Inc. (INSP)
After hours:
- GlobeNewswire
Inspire Medical Systems, Inc. Announces FDA Approval for Pediatric Patients with Down Syndrome
MINNEAPOLIS, March 21, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that it has received approval from the Food and Drug Administration (FDA) to offer Inspire therapy to pediatric patients with Down syndrome. “Since our first FDA approval in 2014, the research team at Mass Eye a
- Insider Monkey
Inspire Medical Systems (INSP) Outperformed on 2023 Revenue Guidance
Alger Capital, an investment management company, released its “Alger Small Cap Focus Fund” fourth quarter investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund underperformed the Russell 2000 Growth Index. The Energy and Communication Services sectors contributed to the fund’s relative performance in the quarter, while Consumer Discretionary […]
- GlobeNewswire
Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in Belgium
MINNEAPOLIS, March 09, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that it has received countrywide reimbursement approval in Belgium, effective immediately, at rates consistent with other countries around the world. “The healthcare team at Antwerp University Hospital (UZA) in
